Hepatitis C

 

<p style="\&quot;text-align:" justify;\"="">\r\n Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.

\r\n

  • Recent Advances in Hepatitis C therapy
  • Prevention of HCV reinfection
  • HCV: Direct Acting Antiviral Era
  • Hepatitis C: Epidemiology
  • HCV Kinetic Models and Implications in Drug Development

Related Conference of Hepatitis C

April 24-25, 2019

International Conference on Gastroenterology and Hepatology

Novotel Budapest City, Budapest, Hungary.
April 24-25, 2019

International conference on Liver and Hepatitis

Novotel Budapest City, Budapest, Hungary
July 08-09-2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

2nd World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia
October 23-24, 2019 |

World Congress on Pancreatic Cancer and Liver Diseases

Tokyo, Japan

Hepatitis C Conference Speakers

Recommended Sessions

Related Journals

Are you interested in